Schizophrenia
0.100
GeneticVariation
disease
GWASCAT
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
30285260
2019
Childhood asthma
0.100
GeneticVariation
disease
GWASCAT
Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies.
31036433
2019
Adult onset asthma
0.100
GeneticVariation
disease
GWASCAT
Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies.
31036433
2019
Child Development Disorders, Pervasive
0.100
GeneticVariation
group
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
Schizophrenia
0.100
GeneticVariation
disease
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
Squamous cell carcinoma of lung
0.100
GeneticVariation
disease
GWASCAT
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
28604730
2017
Carcinoma of lung
0.100
GeneticVariation
disease
GWASCAT
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
28604730
2017
Aggressive behavior
0.100
GeneticVariation
phenotype
GWASCAT
Genome-wide association study of proneness to anger.
24489884
2014
×
CUI:
C0002957
Disease:
Anger
Anger
0.100
GeneticVariation
phenotype
GWASDB
Genome-wide association study of proneness to anger.
24489884
2014
Bipolar Disorder
0.100
GeneticVariation
disease
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
Child Development Disorders, Pervasive
0.100
GeneticVariation
group
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
Schizophrenia
0.100
GeneticVariation
disease
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
Schizophrenia
0.100
GeneticVariation
disease
GWASDB
Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate.
23637625
2013
Attention deficit hyperactivity disorder
0.100
GeneticVariation
disease
GWASDB
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
Attention deficit hyperactivity disorder
0.100
GeneticVariation
disease
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
Major Depressive Disorder
0.100
GeneticVariation
disease
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
Schizophrenia
0.100
GeneticVariation
disease
GWASCAT
Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia.
22883433
2012
Schizophrenia
0.100
GeneticVariation
disease
GWASDB
Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia.
22883433
2012
Schizophrenia
0.100
GeneticVariation
disease
GWASCAT
Genome-wide association study identifies five new schizophrenia loci.
21926974
2011
Schizophrenia
0.100
GeneticVariation
disease
GWASDB
Genome-wide association study identifies five new schizophrenia loci.
21926974
2011
Vitiligo
0.100
GeneticVariation
disease
GWASDB
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
20526339
2010
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.100
GeneticVariation
disease
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
HIV-1, RESISTANCE TO
0.100
GeneticVariation
phenotype
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
0.100
GeneticVariation
phenotype
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
AIDS, PROGRESSION TO
0.100
GeneticVariation
phenotype
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010